Physician profile
Tim Miller
NPI 1922091073
$693.84
in general payments reported to CMS, 2019-2025
12 companies · $143 in 2025
The $143 reported for 2025 was more than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $259 · 2020: $32.07 · 2021: $12.36 · 2022: $65.23 · 2023: $161 · 2024: $20.93 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $325.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $142.66 | 2023 | Allograft Tissue |
| Integra Lifesciences Corporation | $130.88 | 2019 | |
| Abbott Laboratories | $106.67 | 2025 | Proclaim, Eterna |
| Stryker Corporation | $93.88 | 2019 | |
| Novo Nordisk INC | $65.23 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $39.76 | 2023-2025 | |
| Boston Scientific Corporation | $33.46 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Lundbeck LLC | $20.93 | 2024 | Rexulti |
| Shire North American Group INC | $18.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $16.01 | 2019 | |
| Genentech USA, INC. | $13.72 | 2020 | |
| Ge Healthcare | $12.36 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tim Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.